Breaking News
October 23, 2018 - Cancer survivors at risk for heart failure during, after pregnancy
October 23, 2018 - Stanford project brings health education videos to mothers in South Africa
October 23, 2018 - HIV-infected Hispanics at higher risk of developing HPV-related cancers, finds study
October 23, 2018 - Politicians hop aboard ‘Medicare-for-all’ train, destination unknown
October 23, 2018 - Study suggests rising childhood obesity rates as cause for serious hip disease in adolescents
October 23, 2018 - Study highlights existence of barriers to early clinical trial access for adolescents and young adults
October 23, 2018 - Protein sequencing technique could revolutionize biomedical research
October 23, 2018 - Canon Medical to showcase world’s first Ultra-High Resolution CT system at ASTRO 2018
October 23, 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
October 23, 2018 - Cancer stem cells use ‘normal’ genes in abnormal ways
October 23, 2018 - Bad Blood: A conversation with investigative reporter John Carreyrou | News Center
October 23, 2018 - As U.S. fertility rates collapse, finger-pointing and blame follow
October 23, 2018 - Researchers develop promising targeted strategy to treat chemo-resistant blood cancer
October 23, 2018 - Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus
October 23, 2018 - Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer
October 23, 2018 - 11th World Stroke Congress examines high stroke impact in low- and middle-income countries
October 22, 2018 - Breast cancer survival could be extended with two new drug combinations
October 22, 2018 - Researchers discover how acne-causing bacteria resist treatment
October 22, 2018 - Cancer trial shows treating the prostate with radiotherapy improves survival
October 22, 2018 - New hope for a drug to treat lymphedema symptoms
October 22, 2018 - Immune-Based Treatment Helps Fight Aggressive Breast Cancer, Study Finds
October 22, 2018 - Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC
October 22, 2018 - Paternal exercise has significant impact on child’s lifelong metabolic health
October 22, 2018 - Targeting specific genomic mutation in breast cancer improves survival
October 22, 2018 - Loss of tumor protein p53 helps cancer cells grow in hostile environment
October 22, 2018 - IDT to demonstrate CRISPR expertise at European-focused events
October 22, 2018 - Breathing through the nose improves memory consolidation
October 22, 2018 - Recreational Marijuana Now Legal in Canada
October 22, 2018 - Scientists reveal drumming helps schoolchildren diagnosed with autism
October 22, 2018 - A stage IV cancer patient discusses what it means to live well with serious illness
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Innovative strategy opens up new avenue of treatment for anthrax infections
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Drug cocktail that increases lifespan discovered
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Study shows potential positive impact of group prenatal care on birth outcomes
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
HORIBA Medical’s new HELO fully automated hematology platform installed at Torbay Hospital

HORIBA Medical’s new HELO fully automated hematology platform installed at Torbay Hospital

image_pdfDownload PDFimage_print

New HELO fully automated high throughput system at Torbay reduces time taken for routine hematology work

HORIBA UK Ltd, Medical announces the first global installation of its new HELO high throughput fully automated hematology platform in Torbay Hospital. The Laboratory there has achieved UKAS ISO 15189 accreditation. Additionally, the ease of use, fast processing and operational efficiency delivered by HORIBA Medical’s new track-based hematology system has enabled routine hematology work to be smoothed and cut by an hour at the Torbay and South Devon NHS Foundation Trust (TSDFT).

The new HELO fully automated hematology platform installed at Torbay and South Devon NHS Foundation Trust (TSDFT) has smoothed and cut routine work by an hour

The exceptional service and support given by the HORIBA Medical team to achieve this accreditation, which confirms lab quality and competence, has also been recognized by Biomedical Scientists at Torbay. This successful HELO install follows a response to tender in 2017 by HORIBA Medical for a new fully automated hematology platform to replace its 12-year-old Pentra DX 120 hematology analyzers. Alongside the requirement for assistance in verification of the new system via HORIBA’s Quality Accreditation Program (QAP), other ‘must haves’ within the tender were robust white cell linearity, optical platelet counts and nucleated red blood cell counts.

“We have always valued our excellent working relationship with HORIBA Medical and are extremely impressed by their hands-on service response and support,” explained David Strutt, Hematology Technical Manager, Torbay Hospital. “This level of support shone through during HELO’s installation and the demands of the validation process for our lab to continue to meet ISO 15189 quality standards. Also, as the world’s first installation of HELO, we were prepared for the possibility of some teething issues. However, these were minimal and HORIBA couldn’t have done more to sort them out effectively and rapidly.”

The new HELO also met Torbay’s requirements for a tracked hematology platform with flexible layouts to fit within a reconfigured Blood Sciences lab alongside chemistry analyzers to facilitate efficient working. Key to enabling improved workflows is HELO’s novel approach to track – samples can be loaded at any analyzer and the system then disperses them, depending on tests required and individual analyzer capacities.

David Strutt added:

HELO has a different type of track to what I’ve been used to where samples are loaded at the front and taken off at the end. We can simply load sample racks to any Yumizen analyzer linked by the track, HELO then smooths and eats through our workload, with the track reducing turnaround times compared with our previous system. STAT samples are also detected and prioritized wherever you load them directly onto the track, making it very easy to use and giving us more options. Having used other tracks, I can now really see the advantages of HELO’s new more efficient, redistribution approach.”

Also enabling efficient working, HELO displays visual status aides via green, amber and red lights, both as large overall status lights visible from anywhere within the lab, as well as on individual analyzers. “Having immediate warning that the system needs attention allows us to take instant action, whether it’s a reagent change or a Westgard QC alert that has automatically stopped an analyzer,” clarified David Strutt. “Another advantage is the fact that HELO’s open/manual mode uses the same needle as the automated mode, meaning that only one calibration is needed.”

HORIBA Medical’s new HELO solution is an innovative platform designed in consultation with end users to cover all needs of high throughput automated hematology. It offers a highly flexible hematology track system that is fully scalable with many possible configurations, supporting any future changes within a laboratory. It incorporates high throughput Yumizen hematology analyzers processing up to 120 samples/hour. Integrated automatic slide maker/strainers. A comprehensive automated slide digital morphology system is a planned addition for the future. Its automated conveyor (track) and Data Manager ensure intelligent, efficient working with rules based auto-validation.

“We have always championed LEAN working within labs, so when developing our new automation offering, our R&D team approached it with this in mind. As Torbay has confirmed first hand, HELO certainly delivers fast, efficient sample processing which is intelligent and easy to use,” said Mandy Campbell, HORIBA Medical. “We see it as essential to work in close partnership with our customers to meet quality standards. Help is needed not only during the very rigorous ISO 15189 validation process for new equipment such as HELO, but also with ongoing needs for continuing improvement and competency assessment in labs. This is why we introduced QAP to fully support all our customers.”

Source:

http://www.horiba.com/uk/medical/news-events/news/article/first-global-install-of-horiba-medicals-new-track-based-haematology-platform-achieves-quality-accreditation-56021/

Tagged with:

About author

Related Articles